Qingdao Baheal Medical INC.

SZSE:301015 Stock Report

Market Cap: CN¥13.9b

Qingdao Baheal Medical Future Growth

Future criteria checks 3/6

Qingdao Baheal Medical is forecast to grow earnings and revenue by 21.2% and 10.2% per annum respectively. EPS is expected to grow by 21.3% per annum. Return on equity is forecast to be 27.5% in 3 years.

Key information

21.2%

Earnings growth rate

21.3%

EPS growth rate

Healthcare earnings growth23.0%
Revenue growth rate10.2%
Future return on equity27.5%
Analyst coverage

Low

Last updated28 Oct 2024

Recent future growth updates

No updates

Recent updates

Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

Oct 21
Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks

Jun 30
It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks

Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns

Jun 21
Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns

Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762

May 26
Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762

Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet

May 21
Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet

Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

Mar 01
Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

Earnings and Revenue Growth Forecasts

SZSE:301015 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610,9221,316N/A1,0944
12/31/20259,5631,075N/A8024
12/31/20248,473854N/A7364
12/31/20237,889654N/A7754
9/30/20237,975703393531N/A
6/30/20237,414588377492N/A
3/31/20237,336537470589N/A
12/31/20227,510502200306N/A
9/30/20227,336458327411N/A
6/30/20227,436451264314N/A
3/31/20227,286423136170N/A
1/1/20227,052422154181N/A
9/30/20217,038421524543N/A
6/30/20216,797349210228N/A
3/31/20216,291303-66-51N/A
12/31/20205,879273-133-117N/A
12/31/20194,8492104043N/A
12/31/20183,6522583753N/A
12/31/20173,096222149160N/A
12/31/20163,034184N/A88N/A
12/31/20152,39273N/A82N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 301015's forecast earnings growth (21.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 301015's earnings (21.2% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 301015's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 301015's revenue (10.2% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 301015's revenue (10.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 301015's Return on Equity is forecast to be high in 3 years time (27.5%)


Discover growth companies